Transaction in Own Shares

Summary by AI BETAClose X

CT Healthcare Trust PLC has announced the purchase of 6,119 ordinary shares at an average price of 129.62 pence per share on the LSE, with the intention of holding these shares in treasury. Following this transaction, the company now holds 272,786,780 ordinary shares in treasury, with 42,365,529 ordinary shares remaining in issue.

Disclaimer*

CT Healthcare Trust PLC
17 September 2026
 









CT Healthcare Trust plc

 


Transaction in own shares

 










CT Healthcare Trust plc (the "Company") announces that it purchased the following number of its ordinary shares of 1 penny each through J.P. Morgan Securities plc.







Date of purchase:

16 September 2026



Number of ordinary shares purchased:

6,119



Trading venue

LSE



Average price paid per share:

129.62p







The Company intends to hold the purchased shares in treasury.







Following the above transaction, the Company holds 272,786,780 of its ordinary shares in treasury and has 42,365,529 ordinary shares in issue (excluding treasury shares).







The Company's LEI is: 213800HQ3J3H9YF2UI82








Enquiries:

 



 Columbia Threadneedle Investments

 



 Telephone: +44 (0) 207 464 5000








 J.P. Morgan Cazenove

 



 James Bouverat (Sales)




 Telephone: +44 (0) 207 134 2224











 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings